Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pamlab, Inc.
With
Baylor Health Care System
Women's Clinic Shoals
Gainesville Obstetrics & Gynecology
Womens Health Associates
Age
21–39
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Pregnant females, age 21-39, who received either Neevo®/Neevo®DHA or another standard prenatal vitamin (Prenatal vitamins must contain ≤1 mg folic acid, 27-35mg iron, and ≤12mcg vitamin B12).
Clinical diagnosis of pregnancy must have been made at ≤12 weeks of pregnancy and on or after January 1, 2008 and delivery must have occurred on or before December 31, 2009.
Subjects must have been compliant in taking Neevo DHA or other prenatal vitamin.
You may not be if
Subjects should not have taken Prenate®, Prenate®DHA, or Prenate® Elite, which are L-methylfolate-containing prenatal vitamins.
The following supplements within 2 months prior to randomization; 100mg vitamin C, B12 injection \>10mg of B6; \>32mg Iron; \>1.2mg of folate; an L- methylfolate product that is not a prenatal vitamin such as Life Extension methylfolate, Prothera methylfolate, Thorne 5-MTHF, Metanx®, Neevo®, Neevo®DHA, Deplin®, Cerefolin®, or CerefolinNAC®.
History of any anemia other than iron deficiency anemia or leukemia.
Blood transfusion in the 4 months prior to diagnosis of pregnancy.
Clareo Health | A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
